Wolf-Hirschhorn syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:280OMIM:194190Q93.3
Who is this for?
Show terms as
15Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Wolf-Hirschhorn syndrome (WHS), also known as 4p- syndrome or 4p deletion syndrome, is a rare genetic disorder caused by a partial deletion of the short arm of chromosome 4 (4p16.3). The critical region involves the WHSC1 (NSD2) and LETM1 genes. WHS is characterized by a distinctive facial appearance often described as a 'Greek warrior helmet' profile, featuring a broad forehead, prominent glabella, widely spaced eyes (hypertelorism), short philtrum, downturned mouth, and micrognathia. Affected individuals typically present with severe intrauterine and postnatal growth restriction, significant intellectual disability, and marked developmental delay. The syndrome affects multiple body systems. Seizures occur in approximately 90-100% of patients, often beginning in infancy, and may include various types of epilepsy that can be difficult to manage. Congenital heart defects are present in about 50% of cases, most commonly atrial and ventricular septal defects. Skeletal abnormalities, including scoliosis and delayed bone age, are common. Urogenital anomalies (particularly hypospadias in males and renal malformations), hearing loss, and immune deficiency with recurrent infections are also frequently observed. Feeding difficulties are nearly universal in infancy and may require gastrostomy tube placement. There is no cure for Wolf-Hirschhorn syndrome, and management is supportive and multidisciplinary. Treatment focuses on seizure control with antiepileptic medications, surgical correction of heart defects when indicated, nutritional support, and early intervention programs including physical therapy, occupational therapy, and speech therapy. Regular monitoring of growth, hearing, vision, and immune function is recommended. With improved medical care, survival into adulthood is increasingly common, though the degree of intellectual disability remains significant. Prognosis varies depending on the size of the chromosomal deletion and the severity of associated malformations.

Also known as:

Clinical phenotype terms— hover any for plain English:

High anterior hairlineHP:0009890
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Wolf-Hirschhorn syndrome.

View clinical trials →

No actively recruiting trials found for Wolf-Hirschhorn syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Wolf-Hirschhorn syndrome community →

Specialists

15 foundView all specialists →
JT
Jair Antonio Tenorio-Castaño
Specialist
2 Wolf-Hirschhorn syndrome publications
JC
John C Carey
Specialist
3 Wolf-Hirschhorn syndrome publications
RB
Raquel Blanco-Lago
Specialist
2 Wolf-Hirschhorn syndrome publications
IM
Ignacio Málaga
Specialist
2 Wolf-Hirschhorn syndrome publications
HO
Hirofumi Ohashi
Specialist
2 Wolf-Hirschhorn syndrome publications
GK
Gerhard Kluger
Specialist
1 Wolf-Hirschhorn syndrome publication
AL
Amanda Lortz
DELAWARE, OH
Specialist
2 Wolf-Hirschhorn syndrome publications
AB
Agatino Battaglia
Specialist
2 Wolf-Hirschhorn syndrome publications
KK
Konrad Kaminiów
Specialist
1 Wolf-Hirschhorn syndrome publication
OY
Ozgun Yetkin
Specialist
1 Wolf-Hirschhorn syndrome publication
PT
Pınar Tekturk
Specialist
1 Wolf-Hirschhorn syndrome publication
CB
Chantal Biencinto-López
Specialist
2 Wolf-Hirschhorn syndrome publications
CB
Cristina Bel-Fenellós
Specialist
2 Wolf-Hirschhorn syndrome publications
PS
Pasquale Striano
Specialist
1 Wolf-Hirschhorn syndrome publication
SL
Steffen Leiz
Specialist
1 Wolf-Hirschhorn syndrome publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Wolf-Hirschhorn syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Wolf-Hirschhorn syndromeForum →

No community posts yet. Be the first to share your experience with Wolf-Hirschhorn syndrome.

Start the conversation →

Latest news about Wolf-Hirschhorn syndrome

No recent news articles for Wolf-Hirschhorn syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Wolf-Hirschhorn syndrome

What is Wolf-Hirschhorn syndrome?

Wolf-Hirschhorn syndrome (WHS), also known as 4p- syndrome or 4p deletion syndrome, is a rare genetic disorder caused by a partial deletion of the short arm of chromosome 4 (4p16.3). The critical region involves the WHSC1 (NSD2) and LETM1 genes. WHS is characterized by a distinctive facial appearance often described as a 'Greek warrior helmet' profile, featuring a broad forehead, prominent glabella, widely spaced eyes (hypertelorism), short philtrum, downturned mouth, and micrognathia. Affected individuals typically present with severe intrauterine and postnatal growth restriction, significant

At what age does Wolf-Hirschhorn syndrome typically begin?

Typical onset of Wolf-Hirschhorn syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Wolf-Hirschhorn syndrome?

15 specialists and care centers treating Wolf-Hirschhorn syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.